MCE - Delayed Quote EUR

Biotechnology Assets, S.A. (BST.MC)

Compare
0.3090
+0.0040
+(1.31%)
At close: January 10 at 5:35:17 PM GMT+1

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
NameTitlePayExercisedYear Born
Mr. Jaime Feced Rubio President, CEO & Chairman of the Board -- -- --
Dr. Manuel López Nieto Chief Technical Officer -- -- --
Mr. Juan Jose Infante Chief Scientific Officer -- -- --
Mr. Victor Manuel Infante Vinolo Business Development Director & Director -- -- --

Biotechnology Assets, S.A.

Av. del Desarrollo Tecnológico, 11
Jerez de la Frontera
Cádiz, 11591
Spain
34 856 060 603 https://www.biatgroup.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
38

Description

Biotechnology Assets, S.A. develops and markets biotechnological assets for application in the biopharmaceutical, agrochemical, cosmetic, veterinary, and chemical industry sectors in Spain and internationally. The company was founded in 1954 and is based in Cádiz, Spain.

Corporate Governance

Biotechnology Assets, S.A.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

June 6, 2022 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers